Literature DB >> 33562088

Gel-Free 3D Tumoroids with Stem Cell Properties Modeling Drug Resistance to Cisplatin and Imatinib in Metastatic Colorectal Cancer.

Chiharu Sogawa1, Takanori Eguchi1,2, Yuri Namba1,3, Yuka Okusha1,4, Eriko Aoyama2, Kazumi Ohyama1, Kuniaki Okamoto1.   

Abstract

Researchers have developed several three-dimensional (3D) culture systems, including spheroids, organoids, and tumoroids with increased properties of cancer stem cells (CSCs), also called cancer-initiating cells (CICs). Drug resistance is a crucial issue involving recurrence in cancer patients. Many studies on anti-cancer drugs have been reported using 2D culture systems, whereas 3D cultured tumoroids have many advantages for assessing drug sensitivity and resistance. Here, we aimed to investigate whether Cisplatin (a DNA crosslinker), Imatinib (a multiple tyrosine kinase inhibitor), and 5-Fluorouracil (5-FU: an antimetabolite) alter the tumoroid growth of metastatic colorectal cancer (mCRC). Gene expression signatures of highly metastatic aggregative CRC (LuM1 cells) vs. low-metastatic, non-aggregative CRC (Colon26 and NM11 cells) were analyzed using microarray. To establish a 3D culture-based multiplexing reporter assay system, LuM1 was stably transfected with the Mmp9 promoter-driven ZsGreen fluorescence reporter gene, which was designated as LuM1/m9 cells and cultured in NanoCulture Plate®, a gel-free 3D culture device. LuM1 cells highly expressed mRNA encoding ABCG2 (a drug resistance pump, i.e., CSC/CIC marker), other CSC/CIC markers (DLL1, EpCAM, podoplanin, STAT3/5), pluripotent stem cell markers (Sox4/7, N-myc, GATA3, Nanog), and metastatic markers (MMPs, Integrins, EGFR), compared to the other two cell types. Hoechst efflux stem cell-like side population was increased in LuM1 (7.8%) compared with Colon26 (2.9%), both of which were markedly reduced by verapamil treatment, an ABCG2 inhibitor. Smaller cell aggregates of LuM1 were more sensitive to Cisplatin (at 10 μM), whereas larger tumoroids with increased ABCG2 expression were insensitive. Notably, Cisplatin (2 μM) and Imatinib (10 μM) at low concentrations significantly promoted tumoroid formation (cell aggregation) and increased Mmp9 promoter activity in mCRC LuM1/m9, while not cytotoxic to them. On the other hand, 5-FU significantly inhibited tumoroid growth, although not completely. Thus, drug resistance in cancer with increased stem cell properties was modeled using the gel-free 3D cultured tumoroid system. The tumoroid culture is useful and easily accessible for the assessment of drug sensitivity and resistance.

Entities:  

Keywords:  cisplatin resistance; gel-free 3D culture; imatinib (gleevec); metastatic colorectal cancer (mCRC); spheroid; stem cells; tumoroid; tyrosine kinase inhibitor (TKI)

Year:  2021        PMID: 33562088      PMCID: PMC7914642          DOI: 10.3390/cells10020344

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  52 in total

1.  Expression of a Src family kinase in chronic myelogenous leukemia cells induces resistance to imatinib in a kinase-dependent manner.

Authors:  Teodora Pene-Dumitrescu; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

Review 2.  The bone marrow niche in support of breast cancer dormancy.

Authors:  Nykia D Walker; Jimmy Patel; Jessian L Munoz; Madeleine Hu; Khadidiatou Guiro; Garima Sinha; Pranela Rameshwar
Journal:  Cancer Lett       Date:  2015-11-03       Impact factor: 8.679

3.  Imatinib upregulates compensatory integrin signaling in a mouse model of gastrointestinal stromal tumor and is more effective when combined with dasatinib.

Authors:  Ferdinand Rossi; Yasemin Yozgat; Elisa de Stanchina; Darren Veach; Bayard Clarkson; Katia Manova; Filippo G Giancotti; Cristina R Antonescu; Peter Besmer
Journal:  Mol Cancer Res       Date:  2010-08-24       Impact factor: 5.852

Review 4.  The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins.

Authors:  Antonius E van Herwaarden; Alfred H Schinkel
Journal:  Trends Pharmacol Sci       Date:  2005-12-06       Impact factor: 14.819

5.  Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway.

Authors:  P-P Liu; J Liao; Z-J Tang; W-J Wu; J Yang; Z-L Zeng; Y Hu; P Wang; H-Q Ju; R-H Xu; P Huang
Journal:  Cell Death Differ       Date:  2013-10-04       Impact factor: 15.828

6.  Overexpressing microRNA-34a overcomes ABCG2-mediated drug resistance to 5-FU in side population cells from colon cancer via suppressing DLL1.

Authors:  Zheng-Yuan Xie; Fen-Fen Wang; Zhi-Hua Xiao; Si-Fu Liu; Sheng-Lan Tang; Yue-Liang Lai
Journal:  J Biochem       Date:  2020-06-01       Impact factor: 3.387

7.  EGFR and Prion protein promote signaling via FOXO3a-KLF5 resulting in clinical resistance to platinum agents in colorectal cancer.

Authors:  Caroline J Atkinson; Futoshi Kawamata; Cheng Liu; Sunyoung Ham; Balázs Győrffy; Alan L Munn; Ming Q Wei; Andreas Möller; Vicki Whitehall; Adrian P Wiegmans
Journal:  Mol Oncol       Date:  2019-02-08       Impact factor: 6.603

8.  Distinct Dasatinib-Induced Mechanisms of Apoptotic Response and Exosome Release in Imatinib-Resistant Human Chronic Myeloid Leukemia Cells.

Authors:  Juan Liu; Yujing Zhang; Aichun Liu; Jinghua Wang; Lianqiao Li; Xi Chen; Xinyu Gao; Yanming Xue; Xiaomin Zhang; Yao Liu
Journal:  Int J Mol Sci       Date:  2016-04-08       Impact factor: 5.923

9.  Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment.

Authors:  Takanori Eguchi; Chiharu Sogawa; Yuka Okusha; Kenta Uchibe; Ryosuke Iinuma; Kisho Ono; Keisuke Nakano; Jun Murakami; Manabu Itoh; Kazuya Arai; Toshifumi Fujiwara; Yuri Namba; Yoshiki Murata; Kazumi Ohyama; Manami Shimomura; Hirohiko Okamura; Masaharu Takigawa; Tetsuya Nakatsura; Ken-Ichi Kozaki; Kuniaki Okamoto; Stuart K Calderwood
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

10.  Extracellular Vesicles Enriched with Moonlighting Metalloproteinase Are Highly Transmissive, Pro-Tumorigenic, and Trans-Activates Cellular Communication Network Factor (CCN2/CTGF): CRISPR against Cancer.

Authors:  Yuka Okusha; Takanori Eguchi; Manh T Tran; Chiharu Sogawa; Kaya Yoshida; Mami Itagaki; Eman A Taha; Kisho Ono; Eriko Aoyama; Hirohiko Okamura; Ken-Ichi Kozaki; Stuart K Calderwood; Masaharu Takigawa; Kuniaki Okamoto
Journal:  Cancers (Basel)       Date:  2020-04-04       Impact factor: 6.639

View more
  4 in total

1.  Resident stroma-secreted chemokine CCL2 governs myeloid-derived suppressor cells in the tumor microenvironment.

Authors:  May Wathone Oo; Hotaka Kawai; Kiyofumi Takabatake; Shuta Tomida; Takanori Eguchi; Kisho Ono; Qiusheng Shan; Toshiaki Ohara; Saori Yoshida; Haruka Omori; Shintaro Sukegawa; Keisuke Nakano; Kuniaki Okamoto; Akira Sasaki; Hitoshi Nagatsuka
Journal:  JCI Insight       Date:  2022-01-11

Review 2.  Clinical Application Perspectives of Lung Cancers 3D Tumor Microenvironment Models for In Vitro Cultures.

Authors:  Irena Wieleba; Kamila Wojas-Krawczyk; Paweł Krawczyk; Janusz Milanowski
Journal:  Int J Mol Sci       Date:  2022-02-18       Impact factor: 5.923

3.  Metformin combined with local irradiation provokes abscopal effects in a murine rectal cancer model.

Authors:  Mineyuki Tojo; Hideyo Miyato; Koji Koinuma; Hisanaga Horie; Hidenori Tsukui; Yuki Kimura; Yuki Kaneko; Hideyuki Ohzawa; Hironori Yamaguchi; Kotaro Yoshimura; Alan Kawarai Lefor; Naohiro Sata; Joji Kitayama
Journal:  Sci Rep       Date:  2022-05-04       Impact factor: 4.996

4.  Real-Time Fluorescence Visualization and Quantitation of Cell Growth and Death in Response to Treatment in 3D Collagen-Based Tumor Model.

Authors:  Ludmila M Sencha; Olga E Dobrynina; Anton D Pospelov; Evgenii L Guryev; Nina N Peskova; Anna A Brilkina; Elena I Cherkasova; Irina V Balalaeva
Journal:  Int J Mol Sci       Date:  2022-08-09       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.